Inactive Instrument

Calendar BIO-TECHNE Corp Nasdaq

Equities

US8783771004

End-of-day quote Nasdaq
- USD - Intraday chart for BIO-TECHNE Corp

Chart calendar BIO-TECHNE Corp

f8ff.A7bLleXSvHowmMx7RyxUTz0Wt1B_cZ_sj2V8B075jS0.V_f6x5emzjNH_IUcFHRldklj3Gg3R-y7tl0zNRi4tX9o5p3Gl7qMT12vjQ~571bb4e2dddd4023e09511c56de03520

Upcoming events on BIO-TECHNE Corp

Today 09:40 am Leerink Partners Healthcare Crossroads Conference
2024-08-05 Q4 2024 Earnings Release (Projected)
2024-10-28 Q1 2025 Earnings Release (Projected)
2025-02-03 Q2 2025 Earnings Release (Projected)
2025-04-29 Q3 2025 Earnings Release (Projected)

Past events on BIO-TECHNE Corp

2024-05-20 Benchmark Healthcare House Virtual Conference
2024-05-14 05:20 pm BofA Securities Health Care Conference
2024-05-10 12:00 pm American Society of Gene & Cell Therapy Meeting - Abstract 1463
2024-05-09 Ex-dividend day
2024-05-09 12:00 pm American Society of Gene & Cell Therapy Meeting - Abstract 1329
2024-05-09 12:00 pm American Society of Gene & Cell Therapy Meeting - Abstract 1398
2024-05-09 12:00 pm American Society of Gene & Cell Therapy Meeting - Abstract 1397
2024-05-09 08:30 am American Society of Gene & Cell Therapy Meeting
2024-05-08 04:45 pm American Society of Gene & Cell Therapy Meeting
2024-05-08 03:45 pm American Society of Gene & Cell Therapy Meeting
2024-05-08 12:00 pm American Society of Gene & Cell Therapy Meeting - Abstract 868
2024-05-01 09:00 am Q3 2024 Earnings Call
2024-05-01 06:30 am Q3 2024 Earnings Release
2024-04-10 12:00 pm American Association for Cancer Research Meeting - Abstract No: LB393
2024-04-09 12:00 pm American Association for Cancer Research Meeting - Abstract No: 4626
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Abstract No: 3797
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Abstract No: 3773
2024-04-07 04:30 pm American Association for Cancer Research Meeting - Abstract No: 943
2024-03-19 09:45 am KeyBanc Life Sciences & MedTech Forum
2024-03-13 08:30 am Barclays Global Healthcare Conference

Annual results

Fiscal PeriodJune 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
714
722
-1.1%
739
728
1.46%
931
916
1.59%
1 106
1 108
-0.24%
1 137
1 143
-0.51%

1 159

EBITDA
Million USD
Released
Forecast
Spread
264
280
-5.54%
268
254
5.36%
386
378
1.97%
449
449
0.14%
441
446
-1.04%

409

EBIT
Million USD
Released
Forecast
Spread
245
248
-1.47%
246
233
5.66%
362
354
2.29%
421
424
-0.67%
410
412
-0.53%

372

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
112
130
-13.57%
276
230
19.97%
148
200
-25.75%
301
294
2.64%
339
331
2.36%

207

Net income
Million USD
Released
Forecast
Spread
96,1
110
-12.32%
229
181
26.37%
140
169
-17.15%
272
270
0.74%
285
274
4.06%

180

EPS
USD
Released
Forecast
Spread
0,62
0,71
-12.41%
1,46
1,15
26.58%
0,87
1,05
-17.26%
1,66
1,64
1.22%
1,76
1,69
4.05%

1,12

Announcement Date06/08/1904/08/2005/08/2104/08/2208/08/23-

Quarterly results

Fiscal PeriodJune 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
290
279
3.98%
288
287
0.41%
270
282
-4.29%
272
290
-6.26%
294
299
-1.48%
301
308
-2.26%
277
288
-3.72%
273
278
-1.85%
303
293
3.65%

306


290


297


326


333

EBITDA
Million USD
Released
Forecast
Spread
122
116
4.59%
114
113
1.34%
101
102
-1.04%
104
109
-4.49%
116
117
-0.9%
120
122
-1.32%
95,6
99,1
-3.51%
93,2
98,1
-4.92%
109
103
5.74%

112


102


106


124


128

EBIT
Million USD
Released
Forecast
Spread
115
107
6.79%
107
111
-3.64%
93,2
97,5
-4.47%
96,5
103
-5.98%
109
110
-1.33%
112
114
-1.51%
86,9
91,9
-5.41%
81,9
87,2
-6.03%
99,6
94,4
5.52%

103


93,3


96,4


113


117

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
68,8
72,5
-5.1%
79,1
77,2
2.4%
104
64,4
61.11%
66,4
73,9
-10.12%
80,2
77,2
3.92%
88,3
80,5
9.71%
49,6
61,1
-18.87%
33,4
53,7
-37.86%
61,1
56,0
9.09%

63,6


55,0


60,2


78,8


81,6

Net income
Million USD
Released
Forecast
Spread
60,7
57,6
5.4%
61,5
62,6
-1.79%
89,6
52,8
69.62%
50,0
55,4
-9.73%
70,2
63,1
11.3%
75,5
64,0
17.92%
51,0
47,1
8.25%
27,5
43,3
-36.5%
49,1
46,7
5.06%

52,8


41,7


47,0


61,7


64,6

EPS
USD
Released
Forecast
Spread
0,37
0,35
5.97%
0,38
0,38
-0.66%
0,55
0,32
70.22%
0,31
0,34
-9.05%
0,43
0,39
10.26%
0,47
0,40
18.49%
0,31
0,29
6.28%
0,17
0,27
-35.85%
0,31
0,29
7.64%

0,33


0,27


0,30


0,39


0,41

Announcement Date04/05/2204/08/2201/11/2202/02/2303/05/2308/08/2331/10/2301/02/2401/05/24-----